Pediatric midline H3K27M-mutant tumor with disseminated leptomeningeal disease and glioneuronal features: case report and literature review

被引:8
作者
Navarro, Ralph E. [1 ]
Golub, Danielle [2 ]
Hill, Travis [1 ]
McQuinn, Michelle W. [1 ]
William, Christopher [3 ]
Zagzag, David [1 ,3 ]
Hidalgo, Eveline Teresa [1 ]
机构
[1] NYU Langone Hlth, NYU Grossman Sch Med, Dept Neurosurg, Div Pediat Neurosurg, New York, NY USA
[2] Northwell Hlth, Dept Neurosurg, Zucker Sch Med Hofstra Northwell, 300 Community Dr,9 Tower, Manhasset, NY 11030 USA
[3] NYU Langone Hlth, NYU Grossman Sch Med, Dept Pathol, New York, NY USA
关键词
Diffuse intrinsic pontine glioma; Diffuse midline glioma; Leptomeningeal disease; Glioneuronal; BRAIN-STEM GLIOMAS; HIGH-GRADE GLIOMAS; K27M MUTATIONS; DIFFUSE; CHILDREN; METASTASES; CNS;
D O I
10.1007/s00381-020-04892-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background H3K27M-mutant midline lesions were recently reclassified by the World Health Organization (WHO) as "diffuse midline glioma" (DMG) based entirely on their molecular signature. DMG is one of the most common and most lethal pediatric brain tumors; terminal progression is typically caused by local midbrain or brainstem progression, or secondary leptomeningeal dissemination. H3K27M mutations have also been infrequently associated with a histologically and prognostically diverse set of lesions, particularly spinal masses with early leptomeningeal spread. Case presentation A 15-year-old girl after 1 week of symptoms was found to have a T2/FLAIR-hyperintense and contrast-enhancing thalamic mass accompanied by leptomeningeal enhancement along the entire neuraxis. Initial infectious workup was negative, and intracranial biopsy was inconclusive. Spinal arachnoid biopsy revealed an H3K27M-mutant lesion with glioneuronal features, classified thereafter as DMG. She received craniospinal irradiation with a boost to the thalamic lesion. Imaging 1-month post-radiation demonstrated significant treatment response with residual enhancement at the conus. Conclusions This case report describes the unique presentation of an H3K27M-mutant midline lesion with significant craniospinal leptomeningeal spread on admission and atypical glioneuronal histopathological markers. With such florid leptomeningeal disease, spinal dural biopsy should be considered earlier given its diagnostic yield in classifying the lesion as DMG. Consistent with similar prior reports, this lesion additionally demonstrated synaptophysin positivity-also potentially consistent with a diagnosis of diffuse leptomeningeal glioneuronal tumor (DLGNT). In atypical DMG cases, particularly with leptomeningeal spread, further consideration of clinical and histopathological context is necessary for accurate diagnosis and prognostication.
引用
收藏
页码:2347 / 2356
页数:10
相关论文
共 48 条
[1]   Risk stratification in pediatric low-grade glioma and glioneuronal tumor treated with radiation therapy: an integrated clinicopathologic and molecular analysis [J].
Acharya, Sahaja ;
Liu, Jo-Fen ;
Tatevossian, Ruth G. ;
Chiang, Jason ;
Qaddoumi, Ibrahim ;
Gajjar, Amar ;
Walker, David ;
Harreld, Julie H. ;
Merchant, Thomas E. ;
Ellison, David W. .
NEURO-ONCOLOGY, 2020, 22 (08) :1203-1213
[2]   Clinical responses of patients with diffuse leptomeningeal glioneuronal tumors to chemotherapy [J].
Aguilera, Dolly ;
Castellino, Robert Craig ;
Janss, Anna ;
Schniederjan, Mathew ;
McNall, Renee ;
MacDonald, Tobey ;
Mazewski, Claire .
CHILDS NERVOUS SYSTEM, 2018, 34 (02) :329-334
[3]  
ALBRIGHT AL, 1993, NEUROSURGERY, V33, P1026
[4]   Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA [J].
Azad, Tej D. ;
Jin, Michael C. ;
Bernhardt, Lydia J. ;
Bettegowda, Chetan .
NEUROSURGICAL FOCUS, 2020, 48 (01)
[5]   Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH) [J].
Benesch, M ;
Wagner, S ;
Berthold, F ;
Wolff, JEA .
JOURNAL OF NEURO-ONCOLOGY, 2005, 72 (02) :179-183
[6]   Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma [J].
Bronner, Sarah M. ;
Merrick, Karl A. ;
Murray, Jeremy ;
Salphati, Laurent ;
Moffat, John G. ;
Pang, Jodie ;
Sneeringer, Christopher J. ;
Dompe, Nicholas ;
Cyr, Patrick ;
Purkey, Hans ;
Boenig, Gladys de Leon ;
Li, Jun ;
Kolesnikov, Aleksandr ;
Larouche-Gauthier, Robin ;
Lai, Kwong Wah ;
Shen, Xiaoli ;
Aubert-Nicol, Samuel ;
Chen, Yi-Chen ;
Cheong, Jonathan ;
Crawford, James J. ;
Hafner, Marc ;
Haghshenas, Pouyan ;
Jakalian, Araz ;
Leclerc, Jean-Philippe ;
Lim, Ngiap-Kie ;
O'Brien, Tom ;
Plise, Emile G. ;
Shalan, Hadil ;
Sturino, Claudio ;
Wai, John ;
Xiao, Yang ;
Yin, Jianping ;
Zhao, Liang ;
Gould, Stephen ;
Olivero, Alan ;
Heffron, Timothy P. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (16) :2294-2301
[7]   Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications [J].
Buczkowicz, Pawel ;
Bartels, Ute ;
Bouffet, Eric ;
Becher, Oren ;
Hawkins, Cynthia .
ACTA NEUROPATHOLOGICA, 2014, 128 (04) :573-581
[8]   Malignant primary diffuse leptomeningeal gliomatosis with histone H3.3 K27M mutation [J].
Champeaux, C. ;
Drier, A. ;
Devaux, B. ;
Tauziede-Espariat, A. .
NEUROCHIRURGIE, 2018, 64 (03) :198-202
[9]   Primary diffuse leptomeningeal glioneuronal tumors [J].
Cho, Hwa Jin ;
Myung, Jae Kyung ;
Kim, Hannah ;
Park, Chul-Kee ;
Kim, Sung-Ki ;
Chung, Chun Kee ;
Choi, Seung-Hong ;
Park, Sung-Hye .
BRAIN TUMOR PATHOLOGY, 2015, 32 (01) :49-55
[10]  
Cooney TM, 2020, LANCET ONCOL, V21, pE330, DOI 10.1016/S1470-2045(20)30166-2